Last reviewed · How we verify
Restylane® Lyft
At a glance
| Generic name | Restylane® Lyft |
|---|---|
| Sponsor | DeNova Research |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Prospective Evaluation of Facial Cosmetic Procedures (PHASE4)
- Pivotal Study to Evaluate the Efficacy and Safety of Injection With LASBEAU Strong in Correction of Nasolabial Folds (NA)
- Evaluate the Efficacy and Safety of Lidocaine-Containing Hyaluronic Acid Filler in the Treatment of Nasolabial Folds. (NA)
- Restylane + Lidocaine and Restylane Lyft for the Treatment of Nasolabial Folds (PHASE3)
- Restylane® Lyft Filler Injection for Hand Rejuvenation on First Impressions (PHASE1)
- Midfacial Product Selection (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Restylane® Lyft CI brief — competitive landscape report
- Restylane® Lyft updates RSS · CI watch RSS
- DeNova Research portfolio CI